Quantum Circuits’ error-corrected gate-model technology accelerates D-Wave’s dual-platform product roadmap, with plans to make initial gate-model system available in 2026
PALO ALTO, Calif. – January 20, 2026 –…
Category: 6. Business
-
Kevin J. Maroni Elected Chair of National Geographic Society Board of Trustees
WASHINGTON, D.C. (January 20, 2026) — Today, the National Geographic Society announced the election of Kevin J. Maroni as chair of its board of trustees. Having served as a trustee for six years, including as co-vice chair since December 2024,…
Continue Reading
-
Precious Metals Set for Volatile 2026: Annual Forecast Survey Launches
Precious metals are heading into 2026 with strong tailwinds but a growing set of challenges threaten to reshape market dynamics across the complex. Analysts see gold, silver, platinum and palladium breaching new highs throughout the year,…
Continue Reading
-
CEOs cautious on revenue growth despite economic growth
Confidence in the global economy has remained broadly stable heading into 2026, but chief executives are increasingly pessimistic about their own companies’ ability to grow revenues, according to a survey published Monday by…
Continue Reading
-
Goodwin Advises Crescent Capital on the financing of the acquisition of IMS Group by Apheon | News & Events
Goodwin has advised Crescent Capital Group LP (“Crescent”) as mandated lead arranger on the financing arrangements relating to the acquisition of IMS Robotics GmbH and certain of its affiliates (“IMS Group”) by an acquisition vehicle…
Continue Reading
-
BoI claims mutual hedge funds threaten financial stability
In a stormy Knesset Finance Committee session, capital market representatives expressed shock at the Bank of Israel’s approach.
Continue Reading
-
Lilly’s sofetabart mipitecan receives U.S. FDA’s Breakthrough Therapy designation for the treatment of certain patients with platinum-resistant ovarian cancer
INDIANAPOLIS, Jan. 20, 2026 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy…
Continue Reading
-
Global Stocks Fall as Trump Escalates Tariff Threats Against Europe
Key Takeaways
- Global markets sold off on Tuesday, with European stocks extending losses and US equity futures pointing lower.
- Denmark remained a focal point for investors, given its heightened exposure to potential tariff escalation tied to…
Continue Reading
-
Viatris Expands Innovative Portfolio in Cardiovascular Diseases with the Company’s First Launch of Inpefa® (Sotagliflozin) for the Treatment of Heart Failure
Viatris Expands Innovative Portfolio in Cardiovascular Diseases with the Company’s First Launch of Inpefa® (Sotagliflozin) for the Treatment of Heart Failure
Builds on Viatris’ Scientific Leadership and Commercial Legacy in Cardiovascular…
Continue Reading
-
CJEU to decide if authorisation for human drug precludes SPC for veterinary use
In December 2013, Boehringer Ingelheim filed EP 2 934 479 for “Ciclesonide for the treatment of airway disease in horses” at the EPO. Following clinical trials, the company received market authorisation for its product…
Continue Reading